Colon Cancer Clinical Trial
RITUAL Ultivision AI CADe Randomized Controlled Trial
Summary
Ultivision AI is a computer-assisted detection (CADe) device intended to aid endoscopists in the real-time identification of colonic mucosal lesions (such as polyps and adenomas).
Ultivision AI CADe is indicated for white light colonoscopy only.
Full Description
Ultivision AI contains an image processing software and algorithm based on machine learning technology and convolutional neural networks (CNN).
The algorithm's primary function is to identify and highlight the likelihood of the presence of a colon polyp.
Eligibility Criteria
Inclusion Criteria:
Age 45 to 75 years;
Screening or surveillance colonoscopy.
Iinformed consent
Exclusion Criteria:
Colorectal cancer;
Inflammatory bowel disease, including Crohn's disease or ulcerative colitis;
Polyposis syndrome including Familial Adenomatous Polyposis, Cowden syndome, Linch syndrome, Peutz-Jeghers syndrome, MUITYH associated polyposis, familial Colorectal Cancer type X;
Positive Fecal Immunochemical Test;
Use anti-platelet agents or anticoagulants that prevent polyps removal;
Colon resection, not including the appendix;
Subject is pregnant or lactating.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Kansas City Kansas, 66160, United States More Info
Contact
Montréal (Québec) Montreal, H2X 0, Canada More Info
How clear is this clinincal trial information?